Skip to main content
Clinical Trials/TCTR20180507002
TCTR20180507002
Not yet recruiting
Phase 1

Pre-emptive Pregabalin on Postoperative pain after LaparoscopicHysterectomy in Benign Gynecologic disease

Vajira hospital foundation0 sites30 target enrollmentMay 7, 2018

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Postoperative pain scorePostoperative shoulder painPostoperative quantity of analgesic drug useAdverse effects of pregabalin
Sponsor
Vajira hospital foundation
Enrollment
30
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 7, 2018
End Date
May 31, 2018
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Vajira hospital foundation

Eligibility Criteria

Inclusion Criteria

  • 1\. Women ages between 18\-60 years old
  • 2\. Diagnosis for non\-cancerous gynecologic disease
  • 3\. ASA class 1 or 2
  • 4\. BMI \< 35 kg/mm2
  • 5\. Non emergency surgery conditions
  • 6\. Good data communication

Exclusion Criteria

  • 1\. Pregabalin or gabapentin allergy
  • 2\. Pregnancy or breast feeding women
  • 3\. Pathology indicates cancer
  • 4\.Known case of Diabetes mellitus, Hypertension, Kidney diseases, or Diseaes, that associates with nausea/vomitting.
  • 5\. Known case of Chronic pain disease.
  • 6\. Patients who receive other analgesic drugs, anti\-emetic drugs or sedative drugs within 24 hours before operation.
  • 7\. Patients who have the active\-mental disorders
  • 8\.Operation time lasts than 4 hours
  • 9\.Any complications from operation, for example massive blood loss, injuries to adjacent organs, wound infection etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials